News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Retrophin Reports Full-Year 2013 Financial Results



3/27/2014 7:24:51 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Retrophin, Inc. (NASDAQ:RTRX) today reported its financial results for the year ended December 31, 2013.

“2013 was a productive and eventful year for Retrophin,” said Martin Shkreli, Founder and Chief Executive Officer of Retrophin. “We added significant assets to our pipeline of drugs for debilitating and life-threatening diseases for which patients have limited or no available treatment options.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES